Thank you for choosing ACROBiosystems. Would you rate our product and service？
Participate in the survey and you will have the chance to win the gift of your choice!
Thank you for choosing ACROBiosystems. Would you rate our product and service？
Participate in the survey and you will have the chance to win the gift of your choice!
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IL6-M5245 | Mouse | Mouse IL-6 Protein, His Tag |  |
|
|
| IL6-H8218 | Human | Biotinylated Human IL-6 Protein, epitope tag free, ultra sensitivity (primary amine labeling) |  |
|
|
| IL6-H4218 | Human | ActiveMax® Human IL-6 Protein, Tag Free |  |
|
|
Biotinylated Human IL-6, epitope tag free, primary amine labeling (Cat. No. IL6-H8218) stimulates proliferation of TF-1 human erythroleukemic cell line. The EC50 for this effect is 0.2532-0.4489 ng/mL (Routinely tested).
Loaded Biotinylated Human IL-6, epitope tag free, primary amine labeling (Cat. No. IL6-H8218) on SA Biosensor, can bind Human IL-6 R alpha, His Tag (Cat. No. ILR-H4223) with an affinity constant of 45.9 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Pomalidomide | CDC-394; CC-4047; IMiD-1; IMID-4047 | Approved | Celgene Corp | Pomalyst, Imnovid, Actimid, Pomalyst/Imnovid, 安跃 | Mainland China | Multiple Myeloma | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | 2013-02-08 | Central Nervous System Neoplasms; Anemia, Sickle Cell; Sarcoma, Kaposi; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasm Metastasis; Lymphoma, Non-Hodgkin; Primary Myelofibrosis; Lymphoma, Follicular; Prostatic Neoplasms; Sarcoma; Medulloblastoma; Lung Diseases, Interstitial; Multiple Myeloma; Hodgkin Disease; Lymphoma, Large B-Cell, Diffuse; Scleroderma, Systemic; Lymphoma, B-Cell; Bone Marrow Neoplasms; Solid tumours | Details |
| Luminol sodium | MP-1032 | Approved | Selvim, Metrio | Psoriasis; Immune System Diseases | null | 1997-01-01 | Coronavirus Disease 2019 (COVID-19); Immune System Diseases; Psoriasis | Details | ||
| Thalidomide | NSC-66847; NSC-527179; K-17; VP-02 | Approved | Celgene Corp | Talizer, Thalidomide Celgene, Thalidomide Pharmion, Synovir, Thalomid, Thaled | Japan | Leprosy, Lepromatous | Fujimoto Pharmaceutical | 1982-01-01 | HIV Infections; Spondylitis, Ankylosing; Myelodysplastic Syndromes; Idiopathic Pulmonary Fibrosis; Multiple Myeloma; HIV Wasting Syndrome; Erythema Nodosum; Leprosy, Lepromatous; Carcinoma, Hepatocellular | Details |
| Siltuximab | cCLB-8; CNTO-328 | Approved | Eusa Pharma, Janssen Global Services Llc | Sylvant | EU | Castleman Disease | Eusa Pharma (Netherlands) Bv | 2014-04-23 | Respiratory Distress Syndrome, Adult; Lymphoma, Non-Hodgkin; Lung Neoplasms; Castleman Disease; Colorectal Neoplasms; Neoplasms, Plasma Cell; Prostatic Neoplasms; Multicentric Castleman's Disease (MCD); Monoclonal Gammopathy of Undetermined Significance; Multiple Myeloma; Respiratory Tract Infections; Lung Diseases; Myelodysplastic Syndromes; Pancreatic Neoplasms; Smoldering Multiple Myeloma; Pneumonia; Carcinoma, Renal Cell; Ovarian Neoplasms; Head and Neck Neoplasms | Details |
| Lenalidomide | IMID-5013; CDC-5013; CDC-501; ENMD-0997; CC-5013; IMiD-3 | Approved | Celgene Corp | 瑞复美, Revlimid, Revimid (former Brand Name) | EU | Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular | Celgene Europe Bv | 2005-12-27 | Radiculopathy; Carcinoma, Non-Small-Cell Lung; Crohn Disease; Neoplasm Metastasis; Melanoma; Complex Regional Pain Syndromes; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Waldenstrom Macroglobulinemia; Thrombocytopenia; Leukemia, Myeloid, Acute; Lymphoma, T-Cell; Lymphoma, Non-Hodgkin; Prostatic Neoplasms; Lymphoma, Follicular; Reflex Sympathetic Dystrophy; Leukemia, Myeloid; Lymphoma, Mantle-Cell; Multiple Myeloma; Smoldering Multiple Myeloma; Lymphoma, Large B-Cell, Diffuse; Myelodysplastic Syndromes; Blood Protein Disorders; Leukemia-Lymphoma, Adult T-Cell; Paraproteinemias; Anemia; Lymphoma, B-Cell; HIV Infections; Solid tumours; Hematologic Diseases; Lymphoma, B-Cell, Marginal Zone; Lymphoma, T-Cell, Peripheral | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| PXL-01 | PXL-01 | Phase 3 Clinical | Promore Pharma | Tissue Adhesions; Post-surgical adhesions | Details |
| EBI-031 | EBI-031 | Phase 1 Clinical | Sesen Bio | Diabetic macular oedema; Uveitis | Details |
| FB-704A | FB-704; FB-704A | Phase 1 Clinical | Fountain Biopharma | Arthritis, Rheumatoid | Details |
| Anti-interleukin-6 receptor monoclonal antibody (Biocad) | Phase 2 Clinical | Biocad | Autoimmune Diseases | Details | |
| Cis-urocanic acid | Cis-UCA; UCA-001; UCA-002 | Phase 2 Clinical | Herantis Pharma | Dry Eye Syndromes; Urinary Bladder Neoplasms; Xerophthalmia; Dermatitis, Atopic | Details |
| Ziltivekimab | COR-001 | Phase 2 Clinical | Astrazeneca Pharmaceutical Co Ltd | Anemia; Renal Insufficiency, Chronic; Inflammation | Details |
| MEDI-5117 | WBP-216; MEDI-5117 | Phase 1 Clinical | Wuxi Apptec Co Ltd, Medimmune | Arthritis, Rheumatoid | Details |
| Gerilimzumab | GB-224; RYI-008; ARGX-109 | Phase 2 Clinical | Argen-X | Arthritis, Rheumatoid | Details |
| PF-04236921 | PF-4236921; PF-04236921 | Phase 2 Clinical | Pfizer Pharmaceuticals Ltd (China) | Arthritis, Rheumatoid; Lupus Erythematosus, Systemic; Crohn Disease | Details |
| Wogonin | Phase 1 Clinical | Shandong Buchang Pharmaceuticals Co Ltd, Hefei Cosource Medicine Technology, Daewoong Pharmaceutical Co Ltd, China Pharmaceutical University | Respiratory Tract Infections; Neoplasms | Details | |
| Clazakizumab | ALD-518; ALD518-003; BMS-645429; BMS-945429 | Phase 3 Clinical | Alder Biopharmaceuticals | Anemia; Graft vs Host Disease; Arthritis, Rheumatoid; Fatigue; Rejection of organ transplantation; Arthritis, Psoriatic; Inflammation; Cachexia; Carcinoma, Non-Small-Cell Lung; Crohn Disease; Stomatitis | Details |
| Tocilizumab biosimilar (Mycenax Biotech) | Phase 1 Clinical | Mycenax Biotech Inc | Arthritis, Rheumatoid | Details | |
| DMT-210 | DMT-200; DMT-210; DMT-220; SIG-990 | Phase 2 Clinical | Signum Dermalogix | Rosacea; Dermatitis, Atopic | Details |
| Olokizumab | CDP-6038; Anti-IL6-UCB | Phase 3 Clinical | Ucb | Arthritis, Rheumatoid; Coronavirus Disease 2019 (COVID-19); Arthritis; Crohn Disease | Details |
| CD24-Fc | MK-7110; MK7110; HAS-CD24; CD24-Fc-IgG; CD24-Fc | Phase 3 Clinical | Oncoimmune | HIV Infections; Hematopoietic stem cell transplantation (HSCT); Leukemia; Graft vs Host Disease; Coronavirus Disease 2019 (COVID-19); Myelodysplastic Syndromes; Dyslipidemias; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Melanoma | Details |
| Monoclonal Antibody (Mab) sB24M | Phase 1 Clinical | Pyoderma Gangrenosum | Details | ||
| HL-2351 | GX-P4; HL-2351; rhIL-1Ra-hyFc | Phase 1 Clinical | Genexine Inc | Arthritis, Rheumatoid; Cryopyrin-Associated Periodic Syndromes | Details |
This web search service is supported by Google Inc.
A-Z
